Cytek earnings
WebFeb 28, 2024 · Cytek Biosciences expects full year 2024 revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This … WebApr 11, 2024 · Cytek Biosciences (NASDAQ:CTKB) has a market capitalization of $1.22 billion and generates $164.04 million in revenue each year. The company earns $2.58 …
Cytek earnings
Did you know?
WebCytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results. Form 10-K. Q3. Cytek Biosciences Third Quarter 2024 Earnings Conference Call. Cytek Biosciences Reports Third Quarter 2024 Financial Results. Form 10-Q. Q2. Cytek … WebFeb 28, 2024 · Cytek Biosciences, Inc. provided earnings guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024.
WebNov 11, 2024 · Cytek Biosciences ( NASDAQ:CTKB) Third Quarter 2024 Results Key Financial Results Revenue: US$40.5m (up 18% from 3Q 2024). Net income: US$1.67m (up 382% from 3Q 2024). Profit margin: 4.1% (up... WebNov 9, 2024 · Cytek Biosciences, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $40.48 million for the quarter ended September 2024, missing the Zacks...
WebApr 11, 2024 · Cytek Biosciences Inc’s price-earnings (P/E) ratio is currently at 568.0, which is high compared to the Advanced Medical Equipment & Technology industry … WebMar 1, 2024 · Cytek Biosciences, Inc., which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $48.34 million for the quarter ended December 2024, missing the Zacks Consensus...
WebDigital Content Strategist salaries - 1 salaries reported. $102,398 / yr. Technical Sales Specialist salaries - 1 salaries reported. $103,429 / yr. Field Service Engineer salaries - 1 …
WebCytek Biosciences’s upcoming earnings report date is May 10, 2024 which is in 37 days. How were Cytek Biosciences’s earnings last quarter? Cytek Biosciences released its earnings results on Feb 28, 2024. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.042 by $0.018. ... see furtherWebApr 11, 2024 · Cytek Biosciences Inc’s price-earnings (P/E) ratio is currently at 568.0, which is high compared to the Advanced Medical Equipment & Technology industry median of 32.6. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share. putative traductionWebFeb 28, 2024 · Cytek Biosciences, Inc. provided revenue guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 million of revenue contribution from the acquisition of Luminex's Flow Cytometry and … see further in osrsWebSep 30, 2024 · Cytek Biosciences continues to expect full year 2024 revenue to be closer to the high end of the range of $160 million to $168 million. Webcast Information. Cytek will host a conference call to discuss the third quarter 2024 financial results on Wednesday, November 9, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. see function definition jupyter notebookWebFeb 28, 2024 · Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 40% and 3.07%, respectively, for the quarter ended December 2024. Do the numbers … see further in blenderWebNov 8, 2024 · Cytek Biosciences, Inc. ( NASDAQ: CTKB) Q3 2024 Earnings Conference Call November 8, 2024 4:30 PM ET Company Participants Wenbin Jiang - Chief Executive Officer Patrik Jeanmonod - Chief... putative thymidylate synthaseWebFeb 11, 2024 · FREMONT, Calif., Feb. 11, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), today announced it will report financial results for the fourth quarter ... putative vs legal father